“This is my 30th year in biotech, and I’ve given up trying to figure out what the big guys are thinking.”
Stanley Erck, president and CEO of Novavax Inc., on big pharma

“When you pay $11 billion for a company that’s a CEO putting his career on the line.”
Kurt Graves, chairman, president and chief scientific officer at Intarcia Therapeutics Inc., on Gilead Sciences Inc.’s buyout of Pharmasset Inc.

“This was always the Rodney Dangerfield field. It got no respect.”
Jeffrey S. Weber, of the H. Lee Moffitt Cancer Center, on immunotherapy

“Most big pharmas are doing less R and more D.”
Ed Mathers, partner, New Enterprise Associates